Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

October 24, 2016

Amid Election Clamor, Research Issues Surface

Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?

October 17, 2016

Probiotics Help Save the Spine

A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.

October 3, 2016

Look Beyond the Lab For That Next Job

One area where biopharma employment has been increasing is in regulatory affairs and compliance.

September 22, 2016

Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies

Quadruple helices appear to have role in switching genes on or off.

September 12, 2016

Feed a Cold, Starve a Fever: Old World Wisdom Still Holds True

Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.

April 15, 2013

BIO 2013 Session Preview: “Behind the Tech Transfer Headlines”

Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune

March 27, 2012

Biobanking Now and Future Trends

Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research

January 13, 2012

Disruptive Science and Technology: A New Journal

Alan Russell, Ph.D., Editor in Chief

August 23, 2011

Subvisible Particles in Biotech Drugs

E. Morrey Atkinson, Ph.D., CSO, VP of R&D, Cook Pharmica

July 27, 2011

Monitoring Cellular Interactions Using Nanotechnology

Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School

June 28, 2011

A New Tool for Personal Genomics

Gholson Lyon, M.D., Ph.D., Senior Scientist, Principal Investigator, Center for Applied Genomics, The Children’s Hospital of Philadelphia

June 8, 2011

Protein Misfolding and Human Disease

Benjamin Schuler, Ph.D., Professor of Biochemistry, University of Zurich

May 11, 2011

Exploring Biotech’s Past and Predicting Its Future with G. Steven Burrill

G. Steven Burrill, CEO, Burrill & Company

April 29, 2011

Polarized Light Reveals Insights on Proteomics

Sandy M. Simon, Ph.D., Professor, Laboratory of Cellular Biophysics, The Rockefeller University

April 6, 2011

New Nanoparticles for Biomedical Testing

Dr. Jessica Winter, Assistant Professor, Chemical and Biomolecular Engineering and Biomedical Engineering, Ohio State University

March 10, 2011

Drug Repositioning as a Viable Business Model

Aris Persidis, Ph.D., President, Biovista

February 22, 2011

Nonsuppressive Drug Therapy for HIV

Mark G. Fromhold, Ph.D., Vice President, Manufacturing & Business Development, Koronis Pharmaceuticals

February 7, 2011

Creating and Using Plastic Antibodies

Kenneth J. Shea, Ph.D., Professor, Chemistry, School of Physical Sciences, University of California, Irvine

January 21, 2011

Presidential Commission’s Report on Synthetic Biology

Drew Endy is an assistant professor of bioengineering at Stanford University. He earned a BS and MS in civil and environmental engineering, respectively, from Lehigh University and a Ph.D. in biochemical engineering from Dartmouth College.

January 10, 2011

Photograph 51: A Play about Rosalind Franklin

Anna Ziegler, an award-winning playwright, wrote Photograph 51, which looks at Rosalind Franklin’s essential role in the discovery of the double helix.